Valuation: Getinge AB

Market Cap 67.11B 6.69B 5.94B 5.55B 5.05B 9.53B 643B 9.62B 26.01B 329B 25.11B 24.56B 1,055B P/E 2026 *
21.2x
P/E 2027 * 18.9x
Enterprise Value 75.32B 7.51B 6.67B 6.22B 5.67B 10.7B 722B 10.8B 29.19B 369B 28.18B 27.57B 1,184B EV / Sales 2026 *
2.13x
EV / Sales 2027 * 1.95x
Free-Float
79.13%
Yield 2026 *
2.1%
Yield 2027 * 2.29%
1 day+0.12%
1 week-0.12%
Current month-0.69%
1 month-2.72%
3 months+16.65%
6 months+20.17%
Current year+3.68%
1 week 24.44
Extreme 24.44
24.94
1 month 23.92
Extreme 23.925
25.35
Current year 18.99
Extreme 18.99
25.98
1 year 18.99
Extreme 18.99
25.98
3 years 14.84
Extreme 14.84
25.98
5 years 14.84
Extreme 14.84
48.89
10 years 8.31
Extreme 8.31
48.89
Manager TitleAgeSince
Chief Executive Officer 54 01/05/2017
Director of Finance/CFO 48 31/03/2024
Compliance Officer 47 01/10/2020
Director TitleAgeSince
Chairman 65 23/04/2019
Chairman 75 -
Director/Board Member 70 01/01/2007
Change 5-day change 1-year change 3-year change Capi.($)
+0.12%-0.12% - - 6.69B
+0.84%-3.74%-27.56%+1.93% 169B
-0.07%-2.55%-11.59%+13.26% 110B
+0.90%+1.13%-25.66%+3.47% 106B
+1.19%-1.13%-47.68%-11.38% 73.87B
-0.24%+0.69%+2.08%+69.19% 58.98B
+1.32%+3.86%+8.58%+61.88% 51.28B
-0.71%-3.82%-8.68%-31.93% 48.16B
+0.12%-0.17%-17.87%+19.66% 40.84B
-1.01%-1.45%+27.31%-2.67% 32.21B
Average +0.24%-0.86%-11.23%+13.71% 76.69B
Weighted average by Cap. +0.44%-1.30%-17.20%+11.23%

Financials

2026 *2027 *
Net sales 35.32B 3.52B 3.13B 2.92B 2.66B 5.02B 338B 5.06B 13.69B 173B 13.21B 12.93B 555B 37.44B 3.73B 3.31B 3.09B 2.82B 5.32B 359B 5.37B 14.51B 183B 14.01B 13.7B 588B
Net income 3.17B 316M 280M 262M 239M 450M 30.33B 454M 1.23B 15.51B 1.18B 1.16B 49.77B 3.57B 356M 316M 295M 269M 507M 34.21B 512M 1.38B 17.49B 1.34B 1.31B 56.13B
Net Debt 8.21B 818M 727M 678M 618M 1.17B 78.65B 1.18B 3.18B 40.21B 3.07B 3B 129B 6.04B 602M 535M 499M 455M 858M 57.89B 866M 2.34B 29.59B 2.26B 2.21B 94.97B
Logo Getinge AB
Getinge AB is a Sweden-based company operating within healthcare sector. The Company provides hospitals and Life Science institutions with products and solutions aimed at improving clinical outcomes and optimizing workflows. The Company’s reporting segments have the following activities: Acute Care Therapies develops solutions for life-sustaining care in acute health conditions. Life Science offers a comprehensive range of equipment, technical expertise and prevention consultation contamination in pharmaceutical production, biomedical research, production of medical equipment and in various laboratory applications. Surgical Workflows offers products and services for the effective disinfection and sterilization of instruments used in operations, operating tables and others hardware for operating rooms and advanced IT systems for efficient and secure workflows in hospitals.
Employees
11,758
Date Price Change Volume
02/10/26 $24.52 +0.12% 797
01/10/26 $24.49 -0.81% 4,703
30/09/26 $24.69 +0.28% 3,823
29/09/26 $24.62 -2.66% 2,295
28/09/26 $25.29 +3.02% 4,391
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
11
Last Close Price
246.40SEK
Average target price
252.20SEK
Spread / Average Target
+2.35%

Quarterly revenue - Rate of surprise